SALISBURY, N.C. – The Catawba College women's lacrosse program has accepted the Pediatric Cancer Research Foundation's LaCROSSe Out Cancer Challenge. The student-athletes are dedicating their time and talent to raise visibility about the critical need for increasing financial support for pediatric cancer research.
The Catawba Indians have designated Saturday's home finale against Limestone as the program's LaCROSSe Out Cancer game.
Each day, 47 American children are diagnosed with cancer and more children under 20 years old are lost to cancer annually than any other disease. Due to research advances, overall survival rates have grown by 70 percent in the past 40 years. Forms of leukemia that a generation ago were almost universally fatal are now almost universally curable. This is significant because leukemia is still the most commonly diagnosed pediatric cancer. Still, about 20 percent of kids with pediatric cancer do not survive today and two-thirds of those who do suffer long-lasting effects from their treatment. This can include infertility, hormone disruption, reduced muscle mass and cardiac issues, among others. To address these challenges, the PCRF invests in research that pushes the boundaries of science and accelerates the development of new treatments and diagnostic tools specifically for children's and adolescents' developing bodies.
Through the Catawba donation page, over $1,000 has been raised in support of the PCRF this season. Click HERE to donate today or find more information about the campaign.
About the Pediatric Cancer Research Foundation (PCRF)
The Pediatric Cancer Research Foundation (PCRF) is dedicated to funding innovative research that improves outcomes for children battling cancer with the goal of making it possible for them to beat their disease and realize their full potential. Since 1982, PCRF has been at the forefront of driving advancements in pediatric oncology, partnering with researchers, institutions, and donors to find cures and ensure brighter futures for children and families affected by cancer. Visit cure.pcrf-kids.org to learn more.
